Europe IV Hydration Therapy Market: Restraint
The major factors that hinder growth of the Europe IV hydration therapy market include lack of accuracy of infusion pumps and high costs associated with infusion pumps. Pump failures can have high implications on patient’s safety, as these are used for delivering high-risk medications. Thus, the lack of accuracy in delivering the correct volume and dose of fluid can act as a restrain to the market growth.
High burden of foodborne illness is expected to drive the market growth during the forecast period
The increasing burden of foodborne illness such as food poisoning, diarrhea, and others is expected to drive the growth of the Europe IV hydration therapy market over the forecast period. For instance, according to the data published by the World Health Organization (WHO) in June 2019, it was estimated that every minute, 44 people – more than 23 million per year fall sick from eating contaminated food, and an estimated 4700 per year lose their lives in Europe
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients